Drug Trial Radar · NCT05426733
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Jul 5, 2022
Primary completion
Oct 28, 2026
Study completion Oct 28, 2026
Sponsor
- Lead sponsor
- Albireo, an Ipsen CompanyIndustry
- Sponsor type
- Industry
- First posted
- Jun 22, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia
Conditions
- Biliary Atresia
Interventions
OdevixibatDrug
Odevixibat is a small molecule inhibitor of the ileal bile acid transporter (IBAT).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of patients who are alive and have not undergone liver transplantTime frame: From baseline to Week 104
Locations
30 sites in 14 countries. Site status is shown where the registry gives one.
Children's Hospital Colorado
Aurora, Colorado
Children's Healhcare of Atlanta- Emory University school of medicine
Atlanta, Georgia
Indiana University school of Medicine
Indianapolis, Indiana
Boston Children's Hospital
Boston, Massachusetts
Children's Mercy Hospital and Clinics
Kansas City, Missouri
Hassenfeld Children's Hospital at NYU Langone
New York, New York
Columbia University Medical Center New York Presbyterian Morgan Stanley-Komansky Childrens Hospital
New York, New York
The Childrens Hospital at Montefiore Albert Einstein School of Medicine
The Bronx, New York
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Seattle Children's Hospital
Seattle, Washington
Royal Children's Hospital
Parkville, Australia
CHU Sainte-Justine
Montreal, Canada
The Hospital for Sick Children
Toronto, Canada
Guangzhou Women And Childrens Medical Center
Guangdong, China
Children's Hospital of Fudan University
Shanghai, China
Bicêtre Hospital
Le Kremlin-Bicêtre, France
Charité - Universitätsmedizin Berlin
Berlin, Germany
University Children´s Hospital Tuebingen
Tübingen, Germany
ASST Papa Giovanni XXIII
Bergamo, Italy
Azienda Ospedaliera di Padova
Padova, Italy
Hospital Raja Perempuan Zainab II
Kota Bharu, Malaysia
University Malaya Medical Centre
Kuala Lumpur, Malaysia
University Medical Center Groningen
Groningen, Netherlands
Starship Child Health, Te Whatu Ora - Health New Zealand
Auckland, New Zealand
Instytut Pomnik-Centrum Zdrowia Dziecka
Warsaw, Poland
Seoul National University Childrens Hospital
Seoul, South Korea
Hospital Universitari Vall d'Hebron
Barcelona, Spain
Hacettepe İhsan Doğramacı Children's Hospital
Ankara, Turkey (Türkiye)
Akdeniz University Medical Faculty
Antalya, Turkey (Türkiye)
Istanbul University Istanbul Medical Faculty Hospital
Istanbul, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.